Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Reply to: Concerns regarding the validity of the conclusion in a recently published paper on Roche Liat implementation.

Youngs J, Planche T, Carrington D.

J Hosp Infect. 2019 Jul;102(3):356-357. doi: 10.1016/j.jhin.2019.03.003. Epub 2019 Mar 14. No abstract available.

PMID:
30880266
2.

Concerns regarding the validity of the conclusion in a recently published paper on Roche Liat implementation.

Lisby JG, Schneider UV.

J Hosp Infect. 2019 Jul;102(3):355-356. doi: 10.1016/j.jhin.2019.02.011. Epub 2019 Feb 23. No abstract available.

PMID:
30802525
3.

Laboratory evaluation of the Liat HIV Quant (IQuum) whole-blood and plasma HIV-1 viral load assays for point-of-care testing in South Africa.

Scott L, Gous N, Carmona S, Stevens W.

J Clin Microbiol. 2015 May;53(5):1616-21. doi: 10.1128/JCM.03325-14. Epub 2015 Mar 4.

4.

A novel PCR-based point-of-care method facilitates rapid, efficient, and sensitive diagnosis of influenza virus infection.

Schmidt RLJ, Simon A, Popow-Kraupp T, Laggner A, Haslacher H, Fritzer-Szekeres M, Redlberger-Fritz M, Mayer FJ.

Clin Microbiol Infect. 2018 Dec 22. pii: S1198-743X(18)30805-X. doi: 10.1016/j.cmi.2018.12.017. [Epub ahead of print]

PMID:
30583060
5.

Clinical Impact of Rapid Point-of-Care PCR Influenza Testing in an Urgent Care Setting: a Single-Center Study.

Benirschke RC, McElvania E, Thomson RB Jr, Kaul KL, Das S.

J Clin Microbiol. 2019 Feb 27;57(3). pii: e01281-18. doi: 10.1128/JCM.01281-18. Print 2019 Mar.

PMID:
30602445
6.

Assessment of Test Performance and Potential for Environmental Contamination Associated with a Point-of-Care Molecular Assay for Group A Streptococcus in an End User Setting.

Donato LJ, Myhre NK, Murray MA, McDonah MR, Myers JF, Maxson JA, Meek AM, Espy MJ, Furst JW, Karon BS, Binnicker MJ.

J Clin Microbiol. 2019 Jan 30;57(2). pii: e01629-18. doi: 10.1128/JCM.01629-18. Print 2019 Feb.

PMID:
30518542
7.

Accurate Detection of Streptococcus pyogenes at the Point of Care Using the cobas Liat Strep A Nucleic Acid Test.

Wang F, Tian Y, Chen L, Luo R, Sickler J, Liesenfeld O, Chen S.

Clin Pediatr (Phila). 2017 Oct;56(12):1128-1134. doi: 10.1177/0009922816684602. Epub 2016 Dec 22.

PMID:
28006981
8.

Lab-in-a-tube: Real-time molecular point-of-care diagnostics for influenza A and B using the cobas® Liat® system.

Melchers WJG, Kuijpers J, Sickler JJ, Rahamat-Langendoen J.

J Med Virol. 2017 Aug;89(8):1382-1386. doi: 10.1002/jmv.24796. Epub 2017 Mar 14.

PMID:
28213975
9.

Equivalent Performance of the Cobas® Cdiff Test for Use on the Cobas® Liat® System and the Cobas® 4800 System.

Garg SK, Lu K, Duncan J, Peterson LR, Liesenfeld O.

Eur J Microbiol Immunol (Bp). 2017 Dec 5;7(4):310-318. doi: 10.1556/1886.2017.00034. eCollection 2017 Dec 18.

10.

Comparing the Cobas Liat Influenza A/B and respiratory syncytial virus assay with multiplex nucleic acid testing.

Gosert R, Naegele K, Hirsch HH.

J Med Virol. 2019 Apr;91(4):582-587. doi: 10.1002/jmv.25344. Epub 2018 Nov 13.

PMID:
30345524
11.

A rapid and automated sample-to-result HIV load test for near-patient application.

Tanriverdi S, Chen L, Chen S.

J Infect Dis. 2010 Apr 15;201 Suppl 1:S52-8. doi: 10.1086/650387.

PMID:
20225947
12.

Implementation of the cobas Liat influenza point-of-care test into an emergency department during a high-incidence season: a retrospective evaluation following real-world implementation.

Youngs J, Iqbal Y, Glass S, Riley P, Pope C, Planche T, Carrington D.

J Hosp Infect. 2019 Mar;101(3):285-288. doi: 10.1016/j.jhin.2018.12.008. Epub 2018 Dec 16.

PMID:
30562558
13.

Performance comparison of the cobas Liat and Cepheid GeneXpert systems for Clostridium difficile detection.

Granato PA, Hansen G, Herding E, Chaudhuri S, Tang S, Garg SK, Rowell CR, Sickler JJ.

PLoS One. 2018 Jul 24;13(7):e0200498. doi: 10.1371/journal.pone.0200498. eCollection 2018.

14.

Direct Comparison of Alere i and cobas Liat Influenza A and B Tests for Rapid Detection of Influenza Virus Infection.

Nolte FS, Gauld L, Barrett SB.

J Clin Microbiol. 2016 Nov;54(11):2763-2766. Epub 2016 Aug 31.

15.

Implementation of a reformulated Roche® bilirubin Gen.3 reagent did not affect the relationship between BiliChek transcutaneous and Roche total serum bilirubin.

Jara Aguirre JC, Wockenfus AM, Krekelberg BJ, Fine KL, Cook WJ, Karon BS.

Clin Biochem. 2019 Jan;63:148-151. doi: 10.1016/j.clinbiochem.2018.10.001. Epub 2018 Oct 3.

PMID:
30291847
16.

Anti-Rh D activity of commercial intravenous immunoglobulin preparations.

Turner CE, Thorpe SJ, Brasher MD, Thorpe R.

Vox Sang. 1999;76(1):55-8.

PMID:
9933855
17.

Direct Detection of Influenza A and B Viruses in Less Than 20 Minutes Using a Commercially Available Rapid PCR Assay.

Binnicker MJ, Espy MJ, Irish CL, Vetter EA.

J Clin Microbiol. 2015 Jul;53(7):2353-4. doi: 10.1128/JCM.00791-15. Epub 2015 Apr 29.

18.

Prospective evaluation of three rapid molecular tests for seasonal influenza in patients presenting at an emergency unit.

Valentin T, Kieslinger P, Stelzl E, Santner BI, Groselj-Strele A, Kessler HH, Tiran B.

J Clin Virol. 2019 Feb;111:29-32. doi: 10.1016/j.jcv.2019.01.003. Epub 2019 Jan 7.

PMID:
30639844
19.

New taxa of Carpomyini, with special emphasis on Goniglossum (Diptera: Tephritidae: Trypetinae).

Freidberg A.

Zootaxa. 2016 Jul 26;4144(1):54-70. doi: 10.11646/zootaxa.4144.1.2.

PMID:
27470836
20.

Comparison of Six Sample-to-Answer Influenza A/B and Respiratory Syncytial Virus Nucleic Acid Amplification Assays Using Respiratory Specimens from Children.

Banerjee D, Kanwar N, Hassan F, Essmyer C, Selvarangan R.

J Clin Microbiol. 2018 Oct 25;56(11). pii: e00930-18. doi: 10.1128/JCM.00930-18. Print 2018 Nov.

Supplemental Content

Support Center